Interpace Biosciences (IDXG) Reports Q2 EPS of $0.48
Tweet
Share
E-mailGet Alerts IDXG Hot Sheet
Join SI Premium – FREE
Interpace Biosciences (OTC: IDXG) reported Q2 EPS of $0.48, Revenue for the quarter came in at $12 million.
For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Lockheed Martin wins $83 million Army missile contract
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
